Diabetes Research Centers (P30 Clinical Trial Optional)
This Funding Opportunity Announcement (FOA) invites applications for Diabetes Research Centers that are designed to support and enhance the national research effort in diabetes, its complications, and related endocrine and metabolic diseases. Diabetes Research Centers support two primary research-related activities: Research Core services and a Pilot and Feasibility (P and F) program.

DIABETES RESEARCH CENTERS

Thomas Serwold Thomas Serwold PhD Joslin Diabetes Center Joslin Diabetes Center
Dr. Serwold studies how T cells of the immune-system cells are generated—research that helps to shed light on what causes type 1 diabetes and other autoimmune diseases. Since its inception in 1898, the primary mission of the Joslin Diabetes Center has been to care for people with diabetes, and conduct research to provide new knowledge about diabetes and its complications that will lead to new treatments, prevention and/or cure of these disorders.
Rudolph Leibel MD Columbia University Columbia University
Dr. Leibel's research focuses on the genetics of obesity and non-insulin dependent diabetes. His laboratory has mapped, cloned and identified mutations in the obese and fatty genes in rats, mice, and more recently in humans. The Columbia University Diabetes and Endocrinology Research Center provides research support for investigators pursuing research on diabetes and metabolic disorders.
Joel Habener Joel Habener MD Boston Area Boston Area
Dr. Habener is Professor of Medicine at Harvard Medical School and Associate Physician and Chief of the Laboratory of Molecular Endocrinology at Massachusetts General Hospital, Boston. The Boston Area Diabetes Endocrinology Research Center is a consortium of laboratory-based and clinical investigators whose efforts are directed toward addressing many of the major research questions bearing on the etiology, pathogenesis, treatment and cure of type 1 and type 2 diabetes.
Christopher Gardner Christopher Gardner PhD Stanford University Stanford University
Dr. Gardner, Professor of Medicine, Stanford Prevention Research Center, has extensive experience in successful study design, recruitment and retention. The mission of the Stanford Diabetes Research Center is to support basic and clinical research to discover, apply and translate science about diabetes and it complications, to improve health and wellness.
Richard E Ostlund Jr MD Washington University in St Louis Washington University in St Louis
Dr. Richard Ostlund is a professor of Medicine in the Division of Endocrinology, Metabolism and Lipid Research at Washington University School of Medicine in St. Louis. Dr. Ostlund is an acknowledged leader in the field of human cholesterol measurement specializing in general endocrinology, lipid metabolism, diabetes, thyroid disease and nutrition. TThe mission of the Washington University School of Medicine (WUSM) Diabetes Research Center (DRC) is to support and enhance research in diabetes and related metabolic diseases.
Manami Hara Manami Hara PhD University of Chicago University of Chicago
Dr. Hara's research focuses on the identification and characterization of the cells that define the lineage that gives rise to the pancreatic beta cell. The University of Chicago Diabetes Research and Training Center (DRTC) provides resources for the support and coordination of the research and training activities in diabetes and related metabolic and endocrine disorders of a large and growing number of independently funded but highly interactive investigators.
Clay F Semenkovich Clay F Semenkovich MD Washington University in St Louis Washington University in St Louis
Clay F. Semenkovich, M.D., is Chief of the Division of Endocrinology, Metabolism and Lipid Research and Professor of Medicine and of Cell Biology and Physiology. TThe mission of the Washington University School of Medicine (WUSM) Diabetes Research Center (DRC) is to support and enhance research in diabetes and related metabolic diseases.
Pamela L Mellon Pamela L Mellon PhD UCSD-UCLA UCSD-UCLA
We are interested in how the brain controls reproduction through the neuroendocrine system with emphases on development, hormone signaling, gene expression, circadian rhythm, and mouse models of human disease. The overall mission of the UCSD-UCLA DRC is to foster research in theprevention and treatment of diabetes and its complications, and to improve the lives of patients suffering from this devastating disease.
Richard A Flavell Richard A Flavell PhD FRS Yale University Yale University
Dr. Flavell is Sterling Professor of Immunobiology at Yale University School of Medicine, and an Investigator of the Howard Hughes Medical Institute. The Yale Diabetes Research Center (DRC) was established in the spring of 1993 with the goal of promoting research in diabetes and related metabolic and endocrine disorders at the university.
Fumihiko Urano Fumihiko Urano MD PhD Washington University in St Louis Washington University in St Louis
Dr. Urano’s current main focus is to find a cure for juvenile diabetes and genetic forms of diabetes including Type 1 diabetes and Wolfram syndrome using stem cell-based therapeutics and gene-based diagnostics. TThe mission of the Washington University School of Medicine (WUSM) Diabetes Research Center (DRC) is to support and enhance research in diabetes and related metabolic diseases.
Gerald I Shulman Gerald I Shulman MD PhD Yale University Yale University
Dr. Shulman is the George R. Cowgill Professor of Medicine, Cellular & Molecular Physiology and Physiological Chemistry at Yale University, where he serves as Co-Director of the Yale Diabetes Research Center and Director of the Yale Mouse Metabolic Phenotyping Center. The Yale Diabetes Research Center (DRC) was established in the spring of 1993 with the goal of promoting research in diabetes and related metabolic and endocrine disorders at the university.
Bradford Lowell MD PhD Boston Area Boston Area
The Lowell Lab utilizes genetic engineering techniques in mice, in conjunction with electrophysiology, optogenetics, pharmacogenetics and rabies mapping, to elucidate central neurocircuits controlling feeding behavior, body weight homeostasis, and fuel metabolism. The Boston Area Diabetes Endocrinology Research Center is a consortium of laboratory-based and clinical investigators whose efforts are directed toward addressing many of the major research questions bearing on the etiology, pathogenesis, treatment and cure of type 1 and type 2 diabetes.
Joshua D Rabinowitz MD PhD University of Pennsylvania University of Pennsylvania
Our lab aims to achieve a quantitative, comprehensive understanding of cellular metabolism. The Penn Diabetes Research Center participates in the nationwide inter-disciplinary program established over forty years ago by the NIDDK to foster research and training in the areas of diabetes and related endocrine and metabolic disorders.
Kahn, Barbara Barbara Kahn MD Boston Area Boston Area
Barbara B. Kahn is chief of the Division of Endocrinology, Diabetes, and Metabolism at Beth Israel Deaconess Medical Center (BIDMC) and the George Richards Minot Professor of Medicine at Harvard Medical School. The Boston Area Diabetes Endocrinology Research Center is a consortium of laboratory-based and clinical investigators whose efforts are directed toward addressing many of the major research questions bearing on the etiology, pathogenesis, treatment and cure of type 1 and type 2 diabetes.
Matthew Krummel Matthew Krummel, PhD UCSF UCSF

Our work focusses on understanding patterns of immune cell-cell interactions and how these generate “the immune system”.

The University of California San Francisco Diabetes Research Center (UCSF DRC) is one of only 16 research centers established by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to accelerate basic and clinical research into diabetes.
George L King George L King MD Joslin Diabetes Center Joslin Diabetes Center
My laboratory studies the mechanism by which hyperglycemia and insulin resistance are causing diabetic retinopathy, nephropathy and cardiovascular diseases. Since its inception in 1898, the primary mission of the Joslin Diabetes Center has been to care for people with diabetes, and conduct research to provide new knowledge about diabetes and its complications that will lead to new treatments, prevention and/or cure of these disorders.

Diabetes Centers Overview

Diabetes Centers

NIDDK Diabetes Centers

The NIDDK-supported Diabetes Research Centers (DRCs) are part of an integrated program of diabetes and related endocrinology and metabolism research. NIDDK’s Diabetes Centers program supports extramural research institutions that have established an existing base of high-quality, diabetes-related research. Centers provide increased, cost effective collaboration among multidisciplinary groups of investigators at institutions with an established, comprehensive research base in diabetes and related areas of endocrinology and metabolism. DRCs are intended to improve the quality and multidisciplinary nature of research on diabetes by providing shared access to specialized technical resources and expertise. DRCs are intended to facilitate progress in research with the goal of developing new methods to treat, prevent and ultimately cure diabetes mellitus and its complications.

In the Spotlight

Pilot & Feasibility Study
Center Publication
UCSD-UCLA UCSD-UCLA Albert Einstein College of Medicine Einstein University of Michigan Michigan 
Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis., Wheeler, Eleanor, Leong Aaron, Liu Ching-Ti, Hivert Marie-France, Strawbridge Rona J., Podmore Clara, Li Man, Yao Jie, Sim Xueling, Hong Jaeyoung, et al. , PLoS Med, 2017 Sep, Volume 14, Issue 9, p.e1002383, (2017)
NIDDK Center
The mission of the National Mouse Metabolic Phenotyping Centers is to advance medical and biological research by providing the scientific community with standardized, high quality metabolic and physiologic phenotyping services for mouse models of diabetes, diabetic complications, obesity and related disorders.
Diabetes Resource
The primary goal of A2ALL is to provide valuable information on the outcomes of both potential and actual recipients and their donors who have been evaluated for adult-to-adult living donor liver transplantation.